News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
862,580 Results
Type
Article (87706)
Company Profile (727)
Press Release (774123)
Multimedia
Podcasts (216)
Webinars (34)
Section
Business (232874)
Career Advice (4150)
Deals (39902)
Drug Delivery (151)
Drug Development (91268)
Employer Resources (206)
FDA (18321)
Job Trends (17447)
News (397135)
Policy (39865)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3019)
Academic (1)
Accelerated approval (42)
Adcomms (31)
Allergies (138)
Alliances (56797)
ALS (179)
Alzheimer's disease (1832)
Antibody-drug conjugate (ADC) (376)
Approvals (18459)
Artificial intelligence (553)
Autoimmune disease (234)
Automation (42)
Bankruptcy (403)
Best Places to Work (12512)
BIOSECURE Act (23)
Biosimilars (219)
Biotechnology (452)
Bladder cancer (162)
Brain cancer (57)
Breast cancer (582)
Cancer (4767)
Cardiovascular disease (338)
Career advice (3579)
Career pathing (46)
CAR-T (312)
CDC (42)
Celiac Disease (1)
Cell therapy (831)
Cervical cancer (34)
Clinical research (76785)
Collaboration (1809)
Company closure (6)
Compensation (1111)
Complete response letters (81)
COVID-19 (2942)
CRISPR (94)
C-suite (874)
Cystic fibrosis (148)
Data (6186)
Decentralized trials (3)
Denatured (81)
Depression (133)
Dermatology (42)
Diabetes (377)
Diagnostics (7085)
Digital health (31)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (307)
Drug pricing (168)
Drug shortages (19)
Duchenne muscular dystrophy (231)
Earnings (98783)
Editorial (62)
Employer branding (25)
Employer resources (174)
Events (133799)
Executive appointments (886)
FDA (20953)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (12)
Frontotemporal dementia (30)
Funding (1403)
Gene editing (201)
Generative AI (57)
Gene therapy (671)
GLP-1 (979)
Government (5359)
Grass and pollen (4)
Guidances (285)
Healthcare (20805)
HIV (55)
Huntington's disease (54)
IgA nephropathy (89)
Immunology and inflammation (295)
Immuno-oncology (87)
Indications (123)
Infectious disease (3209)
Inflammatory bowel disease (220)
Inflation Reduction Act (14)
Influenza (111)
Intellectual property (223)
Interviews (817)
IPO (17817)
IRA (45)
Job creations (5202)
Job search strategy (2869)
JPM (69)
Kidney cancer (18)
Labor market (102)
Layoffs (648)
Leadership (42)
Legal (10096)
Liver cancer (91)
Longevity (26)
Lung cancer (649)
Lymphoma (363)
Machine learning (51)
Management (66)
Manufacturing (843)
MASH (177)
Medical device (14456)
Medtech (14498)
Mergers & acquisitions (22833)
Metabolic disorders (1195)
mRNA (210)
Multiple sclerosis (166)
NASH (23)
Neurodegenerative disease (401)
Neuropsychiatric disorders (92)
Neuroscience (3148)
Neurotech (1)
NextGen: Class of 2026 (7690)
Non-profit (5092)
Now hiring (73)
Obesity (589)
Opinion (342)
Ovarian cancer (170)
Pain (174)
Pancreatic cancer (192)
Parkinson's disease (319)
Partnered (33)
Patents (448)
Patient recruitment (519)
Peanut (59)
People (66631)
Pharmaceutical (126)
Pharmacy benefit managers (20)
Phase 1 (23813)
Phase 2 (33436)
Phase 3 (25025)
Pipeline (5933)
Policy (301)
Postmarket research (3544)
Preclinical (10675)
Press Release (72)
Prostate cancer (236)
Psychedelics (55)
Radiopharmaceuticals (301)
Rare diseases (951)
Real estate (7426)
Recruiting (81)
Regulatory (28683)
Reports (68)
Research institute (2712)
Resumes & cover letters (653)
Rett syndrome (25)
RNA editing (21)
RSV (71)
Schizophrenia (156)
Series A (249)
Series B (176)
Service/supplier (25)
Sickle cell disease (95)
Special edition (29)
Spinal muscular atrophy (183)
Sponsored (51)
Startups (4337)
State (2)
Stomach cancer (15)
Supply chain (82)
Tariffs (77)
The Weekly (132)
Vaccines (1067)
Venture capital (103)
Weight loss (378)
Women's health (88)
Worklife (23)
Date
Today (11)
Last 7 days (532)
Last 30 days (2230)
Last 365 days (25319)
2026 (6703)
2025 (25541)
2024 (34018)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (91)
Alaska (6)
Arizona (299)
Arkansas (9)
Asia (51370)
Australia (9040)
California (10647)
Canada (2675)
China (1196)
Colorado (341)
Connecticut (433)
Delaware (324)
Europe (117579)
Florida (1407)
Georgia (282)
Hawaii (4)
Idaho (65)
Illinois (706)
India (67)
Indiana (486)
Iowa (21)
Japan (393)
Kansas (138)
Kentucky (28)
Louisiana (16)
Maine (59)
Maryland (1355)
Massachusetts (7969)
Michigan (260)
Minnesota (488)
Mississippi (5)
Missouri (84)
Montana (30)
Nebraska (30)
Nevada (119)
New Hampshire (59)
New Jersey (2799)
New Mexico (29)
New York (2808)
North Carolina (1503)
North Dakota (9)
Northern California (5283)
Ohio (284)
Oklahoma (20)
Oregon (50)
Pennsylvania (2062)
Puerto Rico (25)
Rhode Island (36)
South America (1660)
South Carolina (15)
South Dakota (1)
Southern California (4157)
Tennessee (68)
Texas (1525)
United States (36913)
Utah (232)
Vermont (1)
Virginia (188)
Washington D.C. (54)
Washington State (874)
West Virginia (2)
Wisconsin (93)
862,580 Results for "abilita bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Abilita Bio Changes Name to Abilita Therapeutics and Appoints Joel Edwards as Chief Business Officer
Abilita Bio, a leader in enabling the discovery of membrane protein-targeted therapeutics, announced today the company changed its name to Abilita Therapeutics.
June 1, 2023
·
3 min read
Press Releases
Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New “AutoResearch” Milestone Signals the Rise of Autonomous Research Agents
Open-source breakthrough demonstrates AI agents can run 100+ experiments overnight-reinforcing the agentic R&D paradigm Researgency.ai is bringing to life sciences with Kala Bio (KALA)
March 11, 2026
·
6 min read
Press Releases
Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors
March 27, 2026
·
2 min read
Press Releases
Syneron Bio Announces Completion of $150 Million Series B Financing
April 3, 2026
·
1 min read
Press Releases
Vor Bio Announces $75 Million Private Placement with TCGX
March 27, 2026
·
5 min read
Press Releases
Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026
March 18, 2026
·
3 min read
Press Releases
Genprex to Participate at BIO Europe Spring 2026
March 10, 2026
·
5 min read
Press Releases
INmune Bio Inc. Announces 2025 Results and Provides Business Update
March 30, 2026
·
15 min read
Press Releases
Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo
April 2, 2026
·
7 min read
Press Releases
Bio-Techne Advances Spatial Biology with Modular Expansion of COMET™ Suite
March 25, 2026
·
3 min read
1 of 86,258
Next
